Press releases

2014 Preliminary Results Replay

You have selected Encore.
Encore is InterCall's recording replay service and provides the opportunity to listen to the Event for those who were unable to attend it live or who would like to listen again. The Recording will be available four hours after the Event concludes. The date range that the recording will be accessible is listed below. To access the recording, guests will use the Dial-In Number listed below and the Conference ID 2837070.

Encore Dial In Numbers:

UK National Call: 08717000145
UK LocalCall: 08443386600
UK FreeCall: 08009531533
Std International: +44 (0)1452550000
 
Canada: 1(866) 878-9237
France: 0805111337
Germany: 08001013104
Ireland: 1800931692
Netherlands: 08000234610
Norway: 80016534
Russia: 4996771064
USA: 1 (866) 247-4222

Encore Dates: 13/03/2015 12:00 GMT - 09/04/2015 13:00 GMT

Notes to editors

About Oxford BioMedica

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the "Group") have built a sector leading lentiviral vector delivery platform (LentiVector®), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. The Group has also entered into a number of partnerships, including with Novartis, Bioverativ, Sanofi, Axovant, Orchard Therapeutics, Boehringer Ingelheim/UK Cystic Fibrosis Gene Therapy Consortium/Imperial Innovations, GC LabCell and Immune Design, through which it has long-term economic interests in other potential gene and cell therapy products. Oxford BioMedica is based across several locations in Oxfordshire, UK and employs more than 320 people. Further information is available at www.oxfordbiomedica.co.uk.

For further information please contact

Oxford BioMedica plc

John Dawson, Chief Executive Officer

Stuart Paynter, Chief Financial Officer

Tel: +44 (0)1865 783 000

 

Financial and corporate communications enquiries:

Consilium Strategic Communications
Mary-Jane Elliott/Matthew Neal/Olivia Manser/Laura Thornton

Tel: +44 (0)20 3709 5700

 

Peel Hunt (Joint Corporate Brokers):

James Steel/Christopher Golden

Tel: +44 (0)20 7418 8900

 

WG Partners (Joint Corporate Brokers):

David Wilson/Claes Spang

Tel: +44 (0)20 3705 9321